Related Experiment Video
Updated: Mar 8, 2026

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
Published on: May 14, 2016
Dietary phytochemical PEITC restricts tumor development via modulation of epigenetic writers and erasers
Jung Eun Park1, Yang Sun1, Sai Kiang Lim2
1School of Biological Sciences, Nanyang Technological University, 60 Nanyang Drive, 637551 Singapore.
Abstract:
Dietary intake of bioactive phytochemicals including the cruciferous vegetable derivative phenethyl isothiocyanate (PEITC) can reduce risk of human cancers, but possible epigenetic mechanisms of these effects are yet unknown. We therefore sought to identify the molecular basis of PEITC-mediated epigenetic tumor restriction. Colon cancer cells treated with low-dose PEITC for >1 month exhibited stable alterations in expression profile of epigenetic writers/erasers and chromatin-binding of histone deacetylases (HDACs) and Polycomb-group (PcG) proteins. Sustained PEITC exposure not only blocked HDAC binding to euchromatin but was also associated with hypomethylation of PcG target genes that are typically hypermethylated in cancer. Furthermore, PEITC treatment induced expression of pro-apoptotic genes in tumor cells, which was partially reversed by overexpression of PcG member BMI-1, suggesting opposing roles for PEITC and PcG proteins in control of tumor progression. These data demonstrate that PEITC regulates chromatin binding of key epigenetic writers/erasers and PcG complexes to restrict tumor development.
Insights
Phenethyl isothiocyanate (PEITC), found in cruciferous vegetables, may prevent cancer by altering epigenetic mechanisms. PEITC impacts histone deacetylases and Polycomb proteins, influencing gene expression and promoting tumor cell death.
Area of Science:
- Oncology
- Epigenetics
- Molecular Biology
Background:
- Dietary phytochemicals, like phenethyl isothiocyanate (PEITC) from cruciferous vegetables, are linked to reduced cancer risk.
- The epigenetic mechanisms underlying PEITC's anti-cancer effects are not well understood.
Purpose of the Study:
- To investigate the molecular basis of phenethyl isothiocyanate (PEITC)-mediated epigenetic tumor restriction.
- To identify how PEITC affects epigenetic regulators in colon cancer cells.
Main Methods:
- Colon cancer cells were treated with low-dose PEITC for over one month.
- Changes in expression profiles of epigenetic writers/erasers and chromatin binding of histone deacetylases (HDACs) and Polycomb-group (PcG) proteins were analyzed.
- Gene expression, including pro-apoptotic genes and PcG target genes, was assessed.
- The effect of BMI-1 overexpression on PEITC-induced changes was evaluated.
Main Results:
- Sustained PEITC exposure led to stable alterations in epigenetic regulators and chromatin binding of HDACs and PcG proteins.
- PEITC blocked HDAC binding to euchromatin and caused hypomethylation of PcG target genes, which are typically hypermethylated in cancer.
- PEITC induced pro-apoptotic gene expression in tumor cells.
- Overexpression of BMI-1 partially reversed PEITC's effects, indicating opposing roles in tumor progression.
Conclusions:
- Phenethyl isothiocyanate (PEITC) regulates the chromatin binding of key epigenetic writers, erasers, and Polycomb complexes.
- These epigenetic modifications induced by PEITC contribute to the restriction of tumor development.
- PEITC and Polycomb proteins appear to have opposing roles in controlling cancer progression.
More Related Videos
Related Concept Videos
Abnormal Proliferation
Cancer Prevention
Some...
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Mitogens and the Cell Cycle
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...

